5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells-Reference-Cited by-同舟云学术

5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells

Published:2017-07-07 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Guo Xueyang,Zheng Hang,Luo Weiren,Zhang Qianbing,Liu Jingxian,Yao Kaitai

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-04756-9.pdf

Reference45 articles.

1. Wu, A. et al. Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma. Cancer letters 330, 181–189 (2013).

2. Lun, S. W. et al. CD44 + cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. PloS one 7, e52426 (2012).

3. Beck, B. & Blanpain, C. Unravelling cancer stem cell potential. Nature reviews. Cancer 13, 727–738 (2013).

4. Silva, I. A. et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer research 71, 3991–4001 (2011).

5. Akunuru, S., James Zhai, Q. & Zheng, Y. Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity. Cell death & disease 3, e352 (2012).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

2. Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy;Critical Reviews in Oncology/Hematology;2024-04

3. Recent Advances in the Targeting of Head and Neck Cancer Stem Cells;Applied Sciences;2023-12-15

4. Combinations of radiotherapy with immunotherapy in nasopharyngeal carcinoma;International Immunopharmacology;2023-12

5. CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma;Journal of Experimental & Clinical Cancer Research;2023-11-22